Mix and match vaccines, says Kiran Mazumdar-Shaw
In an exclusive conversation with Fortune India, the executive chairperson of Biocon says India should immediately start mixing and matching existing vaccines to accelerate the vaccination drive.
pfizer company
July 2021
May 2021
March 2021
February 2021
January 2021
Scarcity-hit India looks for imported vaccines
At a time when the entire world is frantically trying to procure more vaccine doses, it is going to be a protracted struggle for India.
Godrej’s hot bet on cold storage
The Covid-19 pandemic has amplified the importance of cold-chain infrastructure, and Godrej Appliances’ medical refrigeration business is making the most of the opportunity.
Covid-19 vaccine: How ready is India’s supply chain?
As India starts the second phase of its Covid-19 vaccine deployment, the question on the viability of its supply chain network, and its cold storage capability, has become more pertinent than ever.
How Godrej joined the global vaccination drive
Godrej & Boyce has built an array of made-in-India ultra-low temperature freezers for the world.
Covid-19 vaccine: Ready, set, roll-out
With two vaccines having received emergency use authorisation, India is prepared to meet the logistical challenge. For now, the deployment has begun with the vaccination of healthcare workers.
Pfizer Covid-19 vaccine gives India a miss, for now
Pharma giant has withdrawn its EUA application in India for now; says it will supply vaccines only through government contracts.
Covid-19 vaccines: India to face a problem of plenty
Prices of vaccines may crash in the next few months. The vaccine makers will have to strike while the iron is hot.
With five vaccines, Serum set for global race
Besides Covishield, four more Covid-19 vaccines are under preparation at the world’s largest vaccine company in Pune as demand from across the globe spikes.
Hope floats for Covid-19 vaccine candidates in India
The DCGI has given the nod for two vaccines and phase 1 of the vaccination process is expected to begin soon. Zydus Cadila’s vaccine candidate has also been cleared for phase 3 trials.
